Anavex Life Sciences Corp (AVXL)

[falconer66a]

Yes, a lengthy, protracted clinical safety and efficacy period might be expected for the new Flex spasticity drug --- if it were conventional.

But, crucially, the active ingredient derives from some existing GRAS (generally accepted as safe) food component; merely placed by Flex in an oral pill form that is most-easily absorbed in oral, esophogeal, and stomach tissues.

Flex's claim of clinical availability of their drug to treat motor neuron hyperexitabiilty in 2017 is reasonable.